Fool.com
The World's Greatest Investing Community
Results 71 - 80 of 1582 : Previous 4 5 6 7 8 9 10 11 12 Next
This Trick Could Haunt Your Portfolio Forever
Beating estimates isn't the same as growth.
A Big Upgrade for Electro-Optical Sciences
This bullish call comes from more than just one analyst.
4-Star Stocks Poised to Pop: Elan
Market-trouncing returns could be written in these four stars.
Taking the Drug Industry's Temperature
Covance and Icon hint at broader pharmaceutical R&D trends.
Swine Flu Doesn't Need to Save Novartis
The company is looking healthy all on its own.
It's their loss.
Not 50% Growth, but We'll Take It
Double-digit growth is still pretty good.
Elan's Headed in the Right Direction
Almost in the black.
Beat Earnings, Stock Down, Rinse and Repeat
Not a good trend.
Nibbles Here and There at Forest Labs
Forest Laboratories banks on its usual strategy to offset generic-drug threats.
Results 71 - 80 of 1582 : Previous 4 5 6 7 8 9 10 11 12 Next
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK